Mazen holds the position of Deputy Chief Executive Officer, and acting Chief Executive Officer of Imperial College London Diabetes Centre following a number of years as General Manager, having steered its rapid growth.
He began his career at Mubadala and soon carved a reputation for his business abilities, with a specialism in healthcare. For more than ten years, he has been involved in almost every one of Mubadala’s healthcare projects. Key projects include Tawam Molecular Imaging Centre, the National Reference Laboratory, Healthpoint, and the Imperial College London Diabetes Centre in Al Ain, which Mazen spear-headed from design stage through to build and implementation.
Mazen has ensured the high performance of ICLDC within his management role, helping the team exceed expectations across KPIs, patient flow and satisfaction, and growing the Centre overall by more than 300% in the first two years following inception in 2011.
Mazen was a member of Imperial College London Diabetes Centre’s Executive Team, since its creation in 2015, as well as managing the administrative functions of the organization. During this time, Mazen demonstrated his abilities in leadership, strategic thinking, and teamwork, to deliver a year on year growth of Imperial College London Diabetes Centre.
Executive and Medical Director
Consultant Physician and Endocrinologist
With a special interest in thyroid disorders and insulin treatment, Dr Saf Naqvi also has a niche specialsm in carrying out complex hormone investigations. He is a Certified General and Metabolic Physician, specialising in the management of hormone disorders. Dr Saf has a wealth of experience, gathered from a career in the UK. Having led diabetes care in hospitals and the community, he has helped develop and maintain high standards wherever he has practiced. He was appointed Medical Director and joined the Executive Team at Imperial College London Diabetes Centre in 2015.
Director of Operations
As Director of Operations at ICLDC, Shukri Abu Ata has been overseeing the day to day running of Imperial College Diabetes Centre since its opening in 2006. A larger than life character, Shukri has embodied the patient-led approach at ICLDC, playing his part in making it a leading diabetes centre in the Gulf Region. Shukri also has a unique place in the history of ICLDC, having been part of the original construction of the Centre and later, as the Centre expanded, being a catalyst in the evolvement and further enhancement of the building and its facilities. He arrived in the UAE in the late 1980s, as a licensed pharmacist, developing his interest in diabetes. Shukri was appointed as a member to the Executive Team at Imperial College London Diabetes Centre in 2015.
Chief Financial Officer
Rohit Gupta oversees all financial responsibilities for Imperial College London Diabetes Centre, supervising general and financial accounting procedures, as well as the Centre’s insurance function and revenue cycle management. Rohit brings over 15 years of experience in healthcare to his role, with a depth of fiancial experience including roles in Mubadala Healthcare, as well as start-ups, consultancy management firms and Fortune 500 companies throughout India, South Africa, Singapore and the Middle East. His experience and expertise includes strategic finance and business planning, resource mobilisation, project monitoring and execution, mergers and acquisitions, finance IT transformation initiatives, corporate governance and financial controllership. He has a Bachelor of Law from HNB University India and a Master of Business Administration (MBA) from the Indian Institute of Management Indore, India. Rohit joined the Executive Team at Imperial College London Diabetes Centre in 2015.